Kofinas Fertility Group

New York, New York 10006

Medical Director: George D. Kofinas, MD

Kofinas Fertility Group, located in New York, offers comprehensive fertility care under the guidance of Medical Director George D. Kofinas, MD. The practice provides a full range of services including IVF, egg freezing, donor egg programs, and surrogacy support, helping patients navigate their unique path to parenthood with personalized treatment plans.

The clinic's results speak to their commitment to excellence, with live birth rates of 62.30% for patients under 35 and 47.70% for those ages 35-37. In 2022 alone, they completed 1,022 treatment cycles, reflecting their experience in helping families grow. What sets Kofinas Fertility Group apart is their understanding that fertility treatment can feel overwhelming – they focus on providing clear communication and compassionate care throughout your journey. Whether you're just beginning to explore your options or have been on this path for a while, their team works to ensure you feel informed and supported at every step, helping transform what can be a complex process into a manageable experience.

Services Offered

IVF

In vitro fertilization — eggs are retrieved and fertilized in a lab, then transferred to the uterus.

Egg Freezing

Oocyte cryopreservation — eggs are retrieved and frozen for future use.

Donor Egg

Uses eggs from a screened donor for patients who cannot use their own.

Surrogacy

Gestational carrier arrangements — an embryo is transferred to a surrogate who carries the pregnancy.

Success Rates

Success rates reflect live births per intended egg retrieval, as reported to the CDC for the 2022 reporting year. Rates vary based on individual patient factors.

Age GroupFresh TransfersFrozen TransfersNat'l Avg
Under 3562.30%+13.968.80%48.4%
35–3747.70%+11.759.40%36%
38–4024.30%+0.754.90%23.6%
Over 4011.00%+1.545.50%9.5%

Based on 1,022 total cycles reported. National averages computed across all reporting clinics.

Physicians

Nearby Clinics

Data on this page is sourced from the CDC's National ART Surveillance System (NASS) and the Society for Assisted Reproductive Technology (SART). Success rates reflect live births per intended egg retrieval for the 2022 reporting year. Individual results vary based on patient age, diagnosis, and treatment protocol.